CLARITIN REDITABS- loratadine tablet, orally disintegrating
Bayer Healthcare LLC.

----------

Claritin ®

RediTabs ®

Drug Facts

Active ingredient (in each tablet)

Loratadine 10 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
itchy, watery eyes
sneezing
itching of the nose or throat

Warnings

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

place 1 tablet on tongue; tablet disintegrates, with or without water

adults and children 6 years and over	1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

Other information

safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn
store between 20° to 25°C (68° to 77°F)
use tablet immediately after opening individual blister
complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Inactive ingredients

anhydrous citric acid, gelatin, mannitol, mint flavor

Questions or comments?

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

Original Prescription Strength
NDC 11523-7157-2

Non-Drowsy*
Claritin ®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

Sneezing
Runny Nose
Itchy, Watery Eyes
Itchy Throat
or Nose

No Water Needed
Melts in Your Mouth

10
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton

TWIN PACK

Two 30ct Cartons
60 RediTabs ®

Original Prescription Strength

NDC 11523-4329-1

Non-Drowsy*
Claritin ®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

Sneezing
Runny Nose
Itchy, Watery Eyes
Itchy Throat
or Nose

No Water Needed
Melts in Your Mouth

60
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton

CLARITIN REDITABS
loratadine tablet, orally disintegrating

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:11523-7157
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	10 mg

Ingredient Name	Strength
Inactive Ingredients
GELATIN (UNII: 2G86QN327L)
MANNITOL (UNII: 3OWL53L36A)
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)

Product Characteristics
Color	white	Score	no score
Shape	ROUND	Size	12mm
Flavor	MINT	Imprint Code	C10
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:11523-7157-2	1 in 1 CARTON	11/27/2002
1		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:11523-7157-3	3 in 1 CARTON	11/27/2002
2		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
3	NDC:11523-7157-4	2 in 1 CARTON	11/27/2002
3		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
4	NDC:11523-7157-7	4 in 1 CARTON	11/27/2002
4		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
5	NDC:11523-7157-8	5 in 1 CARTON	11/27/2002
5		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
6	NDC:11523-7157-9	7 in 1 CARTON	11/27/2002
6		10 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
NDA	NDA020704	11/27/2002

CLARITIN REDITABS
loratadine tablet, orally disintegrating

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:11523-4329
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	10 mg

Ingredient Name	Strength
Inactive Ingredients
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
GELATIN (UNII: 2G86QN327L)
MANNITOL (UNII: 3OWL53L36A)

Product Characteristics
Color	white	Score	no score
Shape	ROUND	Size	12mm
Flavor	MINT	Imprint Code	C10
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:11523-4329-1	2 in 1 PACKAGE, COMBINATION	11/27/2002
1		3 in 1 CARTON
1		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:11523-4329-2	6 in 1 CARTON	11/27/2002
2		10 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
NDA	NDA020704	11/27/2002

Labeler - Bayer Healthcare LLC. (112117283)

Revised: 11/2023

Document Id: 0b616d54-b827-0231-e063-6294a90a8f7e

Set id: b681ea25-d00b-4c8a-8054-cc6f983ce337

Version: 10

Effective Time: 20231130

Bayer Healthcare LLC.